These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6979361)

  • 21. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein.
    Sealey JE; Atlas SA; Laragh JH; Silverberg M; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5914-8. PubMed ID: 42905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of bovine factor VII by hageman factor fragments.
    Radcliffe R; Bagdasarian A; Colman R; Nemerson Y
    Blood; 1977 Oct; 50(4):611-7. PubMed ID: 561632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.
    Kaplan AP; Austen KF
    J Exp Med; 1971 Apr; 133(4):696-712. PubMed ID: 4251126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of bovine prekallikrein to kallikrein. Evidence of limited proteolysis of prekallikrein by bovine Hageman factor (factor XII).
    Takahashi H; Nagasawa S; Suzuki T
    FEBS Lett; 1972 Jul; 24(1):98-100. PubMed ID: 5086625
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference between human and guinea pig Hageman factors in activation by bacterial proteinases: cleavage site shift due to local amino acid substitutions may determine the activation efficiency of serine proteinase zymogens.
    Semba U; Shibuya Y; Tanase S; Nishino N; Makinose Y; Kambara T; Okabe H; Yamamoto T
    Biochim Biophys Acta; 1993 Jan; 1180(3):267-76. PubMed ID: 8422433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor.
    Takahashi H; Nagasawa S; Suzuki T
    J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human plasma prekallikrein. Immunoaffinity purification and activation to alpha- and beta-kallikrein.
    Burger D; Schleuning WD; Schapira M
    J Biol Chem; 1986 Jan; 261(1):324-7. PubMed ID: 2416749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
    Goldsmith GH; Saito H; Ratnoff OS
    J Clin Invest; 1978 Jul; 62(1):54-60. PubMed ID: 659637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of surface-dependent activation of Hageman factor (Factor XII).
    Griffin JH; Beretta G
    Adv Exp Med Biol; 1979; 120B():39-51. PubMed ID: 517240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular assembly in the contact phase of the Hageman factor system.
    Cochrane CG; Griffin JH
    Am J Med; 1979 Oct; 67(4):657-64. PubMed ID: 386794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.
    Revak SD; Cochrane CG; Bouma BN; Griffin JH
    J Exp Med; 1978 Mar; 147(3):719-29. PubMed ID: 632748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.
    Ghebrehiwet B; Randazzo BP; Dunn JT; Silverberg M; Kaplan AP
    J Clin Invest; 1983 May; 71(5):1450-6. PubMed ID: 6304147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.
    Kaplan AP; Goetzl EJ; Austen KF
    J Clin Invest; 1973 Oct; 52(10):2591-5. PubMed ID: 4729052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaphylactic release of a prekallikrein activator from human lung in vitro.
    Meier HL; Kaplan AP; Lichtenstein LM; Revak S; Cochrane CG; Newball HH
    J Clin Invest; 1983 Aug; 72(2):574-81. PubMed ID: 6192147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate.
    Silverberg M; Dunn JT; Garen L; Kaplan AP
    J Biol Chem; 1980 Aug; 255(15):7281-6. PubMed ID: 7391081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoactivation of human plasma prekallikrein.
    Tans G; Rosing J; Berrettini M; Lämmle B; Griffin JH
    J Biol Chem; 1987 Aug; 262(23):11308-14. PubMed ID: 2440889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hageman factor fragment inhibitor in corn seeds: purification and characterization.
    Hojima Y; Pierce JV; Pisano JJ
    Thromb Res; 1980 Oct; 20(2):149-62. PubMed ID: 6782698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.